| Pharmaceutical active ingredients: |
| Tegafur |
| Available forms, composition and doses of Lamar: |
| N / A |
| Lamar medical category: |
| Human:Anticancer drugsChemotherapeutic fluorouracil prodrugsCytotoxic chemotherapy |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| L01BC03 - Tegafur |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Fulfeel | Tegafur | Unidentified Pharmaceutical Company |
| Furafluor | Tegafur | Unidentified Pharmaceutical Company |
| Furflucil | Tegafur | Unidentified Pharmaceutical Company |
| Furofutran | Tegafur | Unidentified Pharmaceutical Company |
| Futraful | Tegafur | Otsuka Pharmaceutical; Agencia Lei Va Hong; Taiho Pharmaceutical; Zuellig Pharma |
| Neberk | Tegafur | Unidentified Pharmaceutical Company |
| Nitobanil | Tegafur | Unidentified Pharmaceutical Company |
| Riol | Tegafur | Unidentified Pharmaceutical Company |
| Sinoflurol | Tegafur | Unidentified Pharmaceutical Company |
| Sunfral | Tegafur | Unidentified Pharmaceutical Company |